Survey of CDC-recognized community pharmacies providing the National Diabetes Prevention Program and impact of the COVID-19 pandemic on program delivery

por Spence, Rowan, Sisson, Evan M., Dixon, Dave L.
Publicado 2022

An ounce of prevention is worth a pound of cure: considerations for pharmacists delivering the National Diabetes Prevention Program

por Dixon, Dave L., Sisson, Evan M., Pamulapati, Lauren G., Spence, Rowan, Salgado, Teresa M.
Publicado 2021

Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review

por Littauer, Sydney L., Dixon, Dave L., Mishra, Vimal K., Sisson, Evan M., Salgado, Teresa M.
Publicado 2017

The cost-effectiveness of pharmacist-physician collaborative care models vs usual care on time in target systolic blood pressure range in patients with hypertension: a payer perspe...

por Jay, Jessica S, Ijioma, Stephen C, Holdford, David A, Dixon, Dave L, Sisson, Evan M, Patterson, Julie A
Publicado 2021

Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series

por Lajthia, Estela, Bucheit, John D., Nadpara, Pramit A., Dixon, Dave L., Caldas, Lauren M., Murchie, Michael, Sisson, Evan M.
Publicado 2019